Ikarian Capital, LLC Kodiak Sciences Inc. Call Options Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$5.04 - $9.48 $129,528 - $243,636
-25,700 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$7.09 - $89.45 $1.01 Million - $12.7 Million
-142,200 Reduced 84.69%
25,700 $199,000
Q3 2021

Nov 15, 2021
BUY
$81.97 - $106.94 $7.84 Million - $10.2 Million
95,600 Added 132.23%
167,900 $16.1 Million
Q2 2021

Aug 16, 2021
BUY
$77.2 - $126.54 $5.58 Million - $9.15 Million
72,300 New
72,300 $6.72 Million

Others Institutions Holding KOD

# of Institutions
97
Shares Held
39M
Call Options Held
6.5K
Put Options Held
5.8K
View Full List

About Kodiak Sciences Inc.

KOD Quotes by TradingView
  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $288M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email